LOGO
LOGO

Health News

New Study Explores Coffee's Impact On Gut-Brain Connection

May 04, 2026 15:30 ET coffee 04052026 lt

Researchers at APC Microbiome Ireland, based at University College Cork, have made an important discovery about how coffee affects the body. For the first time, they closely studied how coffee, whether or not it contains caffeine, interacts with the 'gut-brain axis,' the system that connects the digestive...

  • Study Finds Fish Oil May Slow Brain Recovery After Head Injuries April 27, 2026 14:15 ET

    A study by scientists at the Medical University of South Carolina, published in Cell Reports, suggests that some parts of fish oil may actually slow the brain's recovery after repeated mild head injuries. Fish oil comes from fatty fish like salmon and mackerel. It is popular because it contains omega-3...

  • Late-Night Snacking May Worsen Stress Effects On Gut Health, Study Finds April 24, 2026 13:15 ET

    New research presented at Digestive Disease Week 2026 suggests that eating late at night may intensify the effects of stress on digestive health, with potential consequences for the gut microbiome. "It's not just what you eat, but when you eat it," said lead author Harika Dadigiri, resident physician...

  • Beer Study Finds Nonalcoholic Options May Contain More Vitamin B6 April 23, 2026 13:43 ET

    The study, published in the Journal of Agricultural and Food Chemistry, examined vitamin levels in beer by analyzing the nutritional content of 65 different varieties. Researchers found no significant difference in vitamin B6 levels between alcohol-free lager and regular lager. However, non-alcoholic...

Can Drinking More Water Really Prevent Kidney Stones?

May 01, 2026 13:28 ET kidney 30042026 lt

People who get painful kidney stones again and again are usually told to drink more water to stop them from forming. To test if this really helps, researchers at the Cleveland Clinic conducted a large study. "Kidney stone disease is a chronic condition, punctuated by unpredictable, sometimes excruciatingly...

Ultra-Processed Foods May Cause Lower Attention, Study Says

April 29, 2026 13:59 ET junkfood 29042026 lt

A large study from Australia found that eating even a bit more ultra-processed food might affect how well people can focus and could be linked to a higher risk of dementia, no matter how healthy the rest of their diet is. The research, led by scientist Barbara Cardoso, looked at 2,192 people, consisting...

Trulieve Submits DEA Applications After Marijuana Reclassification To Schedule III

May 01, 2026 16:48 ET dea 02052026 lt

Trulieve Cannabis Corp. (TCNNF) has officially filed applications with the Drug Enforcement Administration to register certain state-sanctioned medical marijuana operations using a new faster track for approval.

Sunshine Boost: Vitamin D Supercharges Breast Cancer Treatment

May 01, 2026 06:59 ET breastcancer 30042026 lt

A new study from Brazil suggests that the "sunshine vitamin" could play a powerful role in improving breast cancer treatment. Researchers at São Paulo State University found that women who received daily vitamin D supplements alongside chemotherapy were far more likely to see their tumors disappear compared to those given a placebo.

  • Oxford-Led Trial Highlights New Early Detection Tool For Endometriosis April 30, 2026 14:23 ET

    The Nuffield Department of Women's & Reproductive Health at the University of Oxford, in collaboration with Serac Healthcare, has published Phase 2 results in The Lancet Obstetrics and Gynaecology, highlighting the potential of a novel molecular imaging agent, 99mTc-maraciclatide, as a non-invasive tool...

  • Ashwagandha And Menopause: A New Evidence For Women's Hormonal Health April 23, 2026 03:59 ET

    Menopause marks a significant biological transition in a woman's life, often accompanied by symptoms such as hot flashes, mood swings, sleep disturbances, and hormonal imbalance. While hormone replacement therapy (HRT) remains a standard treatment, growing interest in non-hormonal, plant-based interventions...

  • View More

Breaking The Silence: A National Push To Recognize Bladder Cancer Early

May 02, 2026 01:24 ET bladder 01052026 lt

Bladder cancer is one of the most commonly diagnosed cancer in the United States- yet it remains one of the least talked about. As Bladder Cancer Awareness Month begins, the Bladder Cancer Advocacy Network (BCAN) is urging the country to pay attention to a disease that affects more than 725,000 people nationwide, with over 84,000 new cases expected this year.

Company Name
Drug
Event
AstraZeneca PLC
( AZN, AZN.L, ZEG.DE, AZN.ST)
Camizestrant (NDA)
04/30/2026
FDA panel to review Camizestrant in ER+/HER2- Early Breast Cancer After at Least 2 Years of Standard Adjuvant Endocrine Therapy whose tumours express ESR1 gene mutations
AstraZeneca PLC
( AZN, AZN.L, ZEG.DE, AZN.ST)
Truqap (sNDA)
04/30/2026
FDA panel to review Truqap in combination with abiraterone for the treatment of adult patients with metastatic hormone-sensitive prostate cancer
Axsome Therapeutics, Inc.
(AXSM)
AXS-05
04/30/2026
FDA decision on AXS-05 for the treatment of Alzheimers disease agitation
argenx SE
( ARGX, ARGX.BR)
VYVGART (sBLA)
05/10/2026
FDA decision on VYVGART with generalized myasthenia gravis who test negative for AChR antibodies (seronegative).
Daiichi Sankyo Company Limited
( DSKYF, 4568.T)
ENHERTU (sBLA)
05/18/2026
FDA decision on ENHERTU followed by paclitaxel, trastuzumab and pertuzumab for the neoadjuvant treatment of adult patients with HER2 positive breast cancer
AstraZeneca PLC
( AZN, AZN.L, ZEG.DE, AZN.ST)
ENHERTU (sBLA)
05/18/2026
FDA decision on ENHERTU followed by paclitaxel, trastuzumab and pertuzumab for the neoadjuvant treatment of adult patients with HER2 positive breast cancer
Eisai Co Ltd
(ESALY.PK, ESALF.PK, 4523.T, EII.SG)
LEQEMBI IQLIK (sBLA)
05/24/2026
FDA decision on LEQEMBI IQLIK, as a weekly starting dose, for the treatment of early Alzheimer’s Disease
Biogen Inc.
(BIIB)
LEQEMBI IQLIK (sBLA)
05/24/2026
FDA decision on LEQEMBI IQLIK, as a weekly starting dose, for the treatment of early Alzheimer’s Disease
BioArctic AB
( BRCTF, BIOA-B.ST, BIOA_B.ST)
Leqembi Iqlik subcutaneous autoinjector (sBLA)
05/24/2026
FDA decision on Leqembi Iqlik Subcutaneous Autoinjector for the treatment of Alzheimer’s disease in patients with Mild Cognitive Impairment or mild dementia stage of disease
MannKind Corp.
(MNKD)
Afrezza (sBLA)
05/29/2026
FDA decision on Afrezza Inhalation Powder in children and adolescents living with type 1 or type 2 diabetes

FDA Achieves Goals In Reducing Animal Testing In Drug Development

April 21, 2026 08:00 ET fda 21042026 lt

The U.S. Food and Drug Administration has announced that vit achieved its key first-year goals in the implementation of its April 2025 Roadmap to Reducing Animal Testing in Preclinical Safety Studies, marking one year of transformative action to modernize drug development through innovative, human-relevant...

Positive Affect Treatment Improves Outcomes In Anhedonia, Study Finds

April 27, 2026 15:17 ET depression 27042026 lt

Anhedonia, the inability to feel pleasure, affects nearly 90% of people with major depression. It is linked to longer and more severe illness, makes recovery harder, and increases the risk of suicidal behavior. It is also seen in conditions like anxiety disorders, post-traumatic stress disorder, substance...

  • FDA Moves To Fast-Track Psychedelic Therapies For Mental Health April 24, 2026 17:45 ET

    The U.S. Food and Drug Administration has rolled out a plan to speed up the development of psychedelic treatments for serious mental health issues, marking a significant change in U.S. healthcare policy.

  • Global Mental Health Crisis: Rising Toll On Youth And Society April 24, 2026 13:52 ET

    Mental health conditions now affect more than a billion people worldwide, yet the public health response has not kept pace with the growing need. Experts warn that depression and anxiety are rising sharply among young people, with one in seven adolescents impacted.

  • Loneliness Linked To Lower Memory In Older Adults, Study Suggests April 21, 2026 15:39 ET

    Researchers recently explored how loneliness affects memory in older adults. They studied over 10,000 people aged 65 and above from 12 countries for six years. At the start, participants self-reported whether they felt highly lonely, somewhat lonely, or not lonely. Notably, none of them had memory...

  • View More

A2MC Recalls Platinum USA Infant Formula In US Over Cereulide Presence

May 04, 2026 09:29 ET rttnewslogo20mar2024 lt

a2 Milk Company Ltd. (ACOPF, A2M.AX), a dairy company, announced a recall of select infant milk formula, manufactured by Synlait Milk Limited and sold only in the United States, citing the presence of cereulide. The recall involves three batches of a2 Platinum USA label infant milk formula, comprising...